[Human chorionic somatomammotropin (HCS) and placental volume].

Area of Science:

• Reproductive biology
• Endocrinology
• Maternal-fetal medicine

Background:

• Human chorionic somatomammotropin (HCS) is produced by the syncytiotrophoblast.
• HCS impacts maternal metabolism, but its role in fetal development is unclear.
• Maternal HCS levels rise during pregnancy and may correlate with placental mass.

Purpose of the Study:

• To investigate the relationship between placental volume and HCS serum levels.
• To determine if HCS secretion is proportional to placental mass.
• To assess the potential of HCS and placental volume measurements for diagnosing pregnancy abnormalities.

Main Methods:

• Ultrasound was used to measure placental volume in 55 pregnant women.
• Serum samples were collected for HCS quantification via radioimmunoassay.
• Measurements were taken from the 12th week of gestation onwards.

Main Results:

• A significant positive correlation (r = 0.546, p < 0.01) was found between placental volume and HCS levels.
• Both placental volume and HCS levels showed a progressive increase throughout gestation.
• Placental volume and HCS levels correlated with fetal biparietal diameters.

Conclusions:

• HCS secretion is proportional to placental volume, likely reflecting syncytiotrophoblast cell mass.
• The findings support HCS as a potential indicator of placental function and growth.
• Further research is needed to establish causality between HCS and fetal growth parameters.